Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Life Span Health
Fingerprint
Dive into the research topics where Bing Tian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases
Tian, B. (PI)
National Institute of Allergy and Infectious Diseases ( Award #5R21AI17629702)
2/1/24 → 12/31/25
Project: Research project
-
Nano-Encapsulated Bromodomain-Containing Protein 4 Inhibitors for New IBD Therapy
Tian, B. (PI)
Crohn's and Colitis Foundation of America ( Award #923759)
1/1/22 → 9/30/24
Project: Research project
-
Nano-Encapsulated Bromodomain-Containing Protein 4 Inhibitors for New IBD Therapy
Tian, B. (PI)
Crohn's and Colitis Foundation of America ( Award #688953)
7/1/20 → 6/30/22
Project: Research project
-
Protein Profiler Microfluidic Electrophoresis System for Proteomics
Tian, B. (PI)
Innovaregi, LLC ( Award #R41GM130206)
12/1/18 → 11/19/20
Project: Research project
-
Pellino-1, a therapeutic target for control of SARS-CoV-2 infection and disease severity
Wang, B., Xia, H., Peng, B. H., Choi, E. J., Tian, B., Xie, X., Makino, S., Bao, X., Shi, P. Y., Menachery, V. & Wang, T., Jan 2025, In: Antiviral research. 233, 106059.Research output: Contribution to journal › Article › peer-review
-
8-Oxoguanine DNA Glycosylase1 conceals oxidized guanine in nucleoprotein-associated RNA of respiratory syncytial virus
Pan, L., Wang, K., Hao, W., Xue, Y., Zheng, X., Basu, R., Hazra, T. K., Islam, A., Hosakote Madaiah, Y., Tian, B., Gagnon, M. G., Ba, X. & Boldogh, I., Oct 2024, In: PLoS pathogens. 20, 10, e1012616.Research output: Contribution to journal › Article › peer-review
Open Access -
BRD4 as an emerging epigenetic therapeutic target for inflammatory bowel disease
Ma, Z., Bolinger, A., Pinchuk, I., Tian, B. & Zhou, J., Jan 2024, Emerging Therapeutic Targets and Drug Delivery Approaches in IBD. Selaru, F. M. & Peters, D. E. (eds.). Academic Press Inc., p. 203-236 34 p. (Advances in Pharmacology; vol. 101).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics
Ma, Z., Bolinger, A. A., Zhou, J. & Tian, B., Jan 2023, In: Expert Opinion on Therapeutic Targets. 27, 1, p. 1-7 7 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
Deletion of cystathionine-γ-lyase in bone marrow-derived cells promotes colitis-associated carcinogenesis
Thanki, K. K., Johnson, P., Higgins, E. J., Maskey, M., Phillips, C. N., Dash, S., Almenas, F. A., Govar, A. A., Tian, B., Villéger, R., Beswick, E., Wang, R., Szabo, C., Chao, C., Pinchuk, I. V., Hellmich, M. R. & Módis, K., Sep 2022, In: Redox Biology. 55, 102417.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations